2005 Annual Meeting | Therapeutic Poisoning: Immunosuppressive Therapy for Non-Neoplastic Neurologic Disease

Date Friday 04/15/05

Time 01:15 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Michael Glantz, MD, FAAN

Topic(s) Multiple Sclerosis

Learning Objectives Upon completion:
Participants should be able to describe the currently available classes of immunosuppressive and myelo-suppressive agents, their neurologic and non-neurologic toxicities, and the practical aspects of their administration; explain the rationale and optimum strategies for the use of these agents in a wide spectrum of primary and secondary nervous system disorders; establish a safe and efficient office-based program for the use of immunosuppressive and myelosuppressive therapies in patients with nervous system diseases; and discuss novel and evolving roles for immunosuppressive therapies in nervous system diseases such as Alzheimer's disease and Parkinson's disease.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
01:15 PM - 01:50 PM		Immunosuppressive Therapy in Demyelinating Disease-How I Do It Patricia K. Coyle, MD, FAAN
01:50 PM - 02:25 PM		Immunosuppressive Therapy in Neuromuscular Disease-How I Do It Jeffrey A. Cohen, MD, FAAN
02:25 PM - 03:00 PM		Immunosuppressive Therapy in the Neurodegenerative Diseases-How I Do It Jody Corey-Bloom, MD, PhD, FAAN
03:00 PM - 03:15 PM		Break
03:15 PM - 03:50 PM		Managing the Toxicity of Immunosuppressive Therapy in the Office Setting Camilo E. Fadul, MD, FAAN, Michael Glantz, MD, FAAN
03:50 PM - 04:05 PM		Case Presentations: Demyelinating Disease Patricia K. Coyle, MD, FAAN
04:05 PM - 04:20 PM		Case Presentations: Neuromuscular Disease Jeffrey A. Cohen, MD, FAAN
04:20 PM - 04:35 PM		Case Presentations: Stem Cell Transplantation Michael Glantz, MD, FAAN
04:35 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Jeffrey A. Cohen, MD, FAAN	Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for gross minsky mogul. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Ratcliffe Harten Galalmaga . Dr. Cohen has received publishing royalties from a publication relating to health care.
Patricia K. Coyle, MD, FAAN	Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Company. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Coyle has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Celgene.
Michael Glantz, MD, FAAN	No disclosure on file
Camilo E. Fadul, MD, FAAN	No disclosure on file
Jody Corey-Bloom, MD, PhD, FAAN	Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group.

��ɫ��

��ɫ��